ISCIX
Price
$54.67
Change
+$0.36 (+0.66%)
Updated
Jun 12 closing price
Net Assets
554.16M
TIDDX
Price
$80.77
Change
+$0.21 (+0.26%)
Updated
Jun 12 closing price
Net Assets
6.61B
Interact to see
Advertisement

ISCIX vs TIDDX

Header iconISCIX vs TIDDX Comparison
Open Charts ISCIX vs TIDDXBanner chart's image
ISCIX vs TIDDX Comparison Chart in %
View a ticker or compare two or three
VS
ISCIX vs. TIDDX commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISCIX is a Hold and TIDDX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TIDDX has more cash in the bank: 6.61B vs. ISCIX (554M). TIDDX pays higher dividends than ISCIX: TIDDX (1.55) vs ISCIX (1.12). ISCIX was incepted earlier than TIDDX: ISCIX (18 years) vs TIDDX (10 years). ISCIX (1.26) is less costly to investors than TIDDX (1.08). TIDDX is a more actively managed with annual turnover of: 41.30 vs. ISCIX (39.00). TIDDX has a lower initial minimum investment than ISCIX: TIDDX (500000) vs ISCIX (1000000). TIDDX annual gain was more profitable for investors over the last year : 14.50 vs. ISCIX (11.63). ISCIX return over 5 years is better than : 18.01 vs. TIDDX (-14.68).
ISCIXTIDDXISCIX / TIDDX
Total Expense Ratio0.991.0892%
Annual Report Gross Expense Ratio1.261.08117%
Fund Existence18 years10 years-
Gain YTD10.2227.313140%
Front LoadN/AN/A-
Min. Initial Investment1000000500000200%
Min. Initial Investment IRAN/AN/A-
Net Assets554M6.61B8%
Annual Yield % from dividends1.121.5572%
Returns for 1 year11.6314.5080%
Returns for 3 years53.2238.55138%
Returns for 5 years18.01-14.68-123%
Returns for 10 years82.1366.55123%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KLAC254.5413.38
+5.55%
KLA Corporation
BTAI1.150.04
+4.05%
BioXcel Therapeutics Inc
EYE18.610.36
+2.00%
National Vision Holdings
PTGX109.830.04
+0.04%
Protagonist Therapeutics
ELMD37.14-0.47
-1.25%
Electromed